May 1, 2024
3 minute read
Biosimilars are a class of pharmaceutical drugs that are highly similar to existing, FDA-approved biological drugs, known as reference products. Biosimilars are developed using advanced biotechnology techniques, and they offer several advantages over traditional generic drugs. Understanding biosimilars is important for healthcare professionals, students, and individuals interested in the pharmaceutical industry.
Why Learn About Biosimilars?
There are several reasons why one may want to learn about biosimilars:
60ju7j|
Find a path to becoming a BioSimilars. Learn more at:
OpenCourser.com/topic/60ju7j/biosimilar
Reading list
We've selected five books
that we think will supplement your
learning. Use these to
develop background knowledge, enrich your coursework, and gain a
deeper understanding of the topics covered in
BioSimilars.
A comprehensive guide to the development, regulation, and use of biosimilars, featuring contributions from experts in the field.
This guide from the World Health Organization provides a comprehensive overview of biosimilars, including their regulatory pathways, clinical evaluation, and quality assurance.
An official guide from the FDA that provides practical information on biosimilars for healthcare providers, including prescribing, monitoring, and patient education.
A comprehensive review of the regulatory and scientific considerations involved in biosimilar development, including case studies and expert commentary.
Provides a comprehensive guide to the regulatory considerations and scientific strategies involved in biosimilar development.
For more information about how these books relate to this course, visit:
OpenCourser.com/topic/60ju7j/biosimilar